0235 Broadcast DATE: September 4, 2007 SUBJECT: RTOG 0235/ACRIN 6668, Amended Amended RTOG 0235/ACRIN 6668, "Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma," Amendment 5. Please see the complete Summary of Changes at: http://www.acrin.org/6668_protocol.html You may download a copy of the protocol for IRB review by accessing the RTOG web site at: http://www.acrin.org/6668_protocol.html. Note: This study is coordinated by ACRIN. If you have any questions about this amendment, please contact Michael Bradley, ACRIN Protocol Associate, 215-717-0839. NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by the cooperative to NCI. Per CTMB Guidelines, amendments must be submitted and approved by local IRBs within 90 days. Expedited review is allowed; however, site IRB requirements take precedence. Please notify your affiliates that are not on e-mail. DATE: November 02, 2006 SUBJECT: RTOG 0235/ACRIN 6668, Amended Amended RTOG 0235/ACRIN 6668, "Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Non-small Cell Lung Carcinoma," Amendment 4. Please see the complete Summary of Changes at: http://www.acrin.org/6668_protocol.html You may download a copy of the protocol for IRB review by accessing the RTOG web site at: http://www.acrin.org/6668_protocol.html. NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by the cooperative to NCI. Per CTMB Guidelines, amendments must be submitted and approved by local IRBs within 90 days. Expedited review is allowed; however, site IRB requirements take precedence. Please notify your affiliates that are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. DATE: June 13, 2006 SUBJECT: RTOG 0235/ACRIN 6668 Amended Amended RTOG 0235/ACRIN 6668, "Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Nonsmall Cell Lung Carcinoma," Amendment 3. Please see the complete Summary of Changes at: http://www.acrin.org/6668_protocol.html. You may download a copy of the protocol for IRB review by accessing the RTOG web site at: http://www.acrin.org/6668_protocol.html. NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by the cooperative to NCI. Per CTMB Guidelines, amendments must be submitted and approved by local IRBs within 90 days. Expedited review is allowed; however, site IRB requirements take precedence. Please notify your affiliates that are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. If you would like to be added/removed from the RTOG broadcast list or wish to update your e-mail address, contact David Corrie at dcorrie@phila.acr.org. Web registration is available 24/7. Information and instructions are at https://silver2.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: December 08, 2005 SUBJECT: RTOG 0235/ACRIN 6668 Amended Amended RTOG 0235/ACRIN 6668,"Positron Emission Tomography Pre- and Post-treatment Assessment for Locally Advanced Nonsmall Cell Lung Carinoma," Amendment 2: Revisions were made to Sections 1, 3, 6, 9, 11,15, and 17 and Appendix II of the protocol. Please see the complete Summary of Changes at http://www.acrin.org/6668_protocol.html. You may download a copy of the protocol for IRB review by accessing the RTOG web site at http://www.acrin.org/6668_protocol.html. NCI policy requires that the "Version Date" on the protocol title page reflect the date the amendment was submitted by RTOG to NCI; for clarity, the broadcast date is provided in parentheses. Per CTMB Guidelines, amendments must be submitted and approved by local IRBs within 90 days. Expedited review is allowed; however, site IRB requirements take precedence. Please notify your affiliates that are not on e-mail. To share a comment or ask a question, access the Headquarters Information and Telephone Listing on the RTOG web site, www.rtog.org, under "Member Info", or call 1-800-227-5463, ext. 4189, which provides a menu to reach the Headquarters departments. If you would like to be added/removed from the RTOG broadcast list or wish to update your e-mail address, contact David Corrie at dcorrie@phila.acr.org. Web registration is available 24/7. Information and instructions available at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html DATE: April 28, 2005 SUBJECT: ACRIN 6668/RTOG 0235, Clarification Clarification for RTOG institutions: ACRIN 6668/RTOG 0235, “Positron Emission Tomography Pre- and Post-treatment Assessment For Locally Advanced Non-Small Cell Lung Carcinoma” was activated by ACRIN, the coordinating group, on March 1, 2005. The protocol and all other information can be accessed via the RTOG web site, http://www.rtog.org/ (no password required). Clicking on the protocol number, “ACRIN 6668/RTOG 0235” will link to ACRIN’s web site. Or institutions can access ACRIN’s web site directly at http://www.acrin.org/6668_protocol.html Patients are registered and forms submitted via ACRIN. Registration to ACRIN 6668 through the ACRIN web site will automatically trigger registration to RTOG 0235. RTOG will provide case credit and $2,000 case reimbursement, and ACRIN will provide $1000 case reimbursement. As a reminder, the two PET scans in this study are considered standard of care imaging for patients with advanced lung cancer and should be billed to patient's insurance. As the coordinating group, ACRIN is responsible for all broadcasts regarding amendments, updates, etc. Once an RTOG institution submits IRB approval and other start up requirements and credentialing criteria are met, the institution is added to ACRIN’s distribution list for all announcements. Questions and concerns should be directed to the ACRIN Protocol Coordinator, Irene Mahon, 215-574-3249, E-mail: imahon@phila.acr.org. Web registration is available 24/7. Information and instructions are at https://silver1.phila.acr.org/Clinical_RTOG/pgIndex.html